Business Wire

Tecnotree Launches DOCS - A 5G Digital Convergent Charging Platform

3.6.2022 13:47:00 EEST | Business Wire | Press release

Share

Tecnotree, the global leader of Digital Business Support Systems, announced today the launch of its 5G enabled Digital Online Charging System (DOCS) solution - a cloud-native microservices-based convergent charging platform designed to cater to both current and futuristic monetization use-cases of Communication and Digital Service Providers.

With flattening ARPUs (Average Revenue Per Unit) and declining loyalty, compounded by an explosion in data consumption, Communication Service Providers (CSPs) are under tremendous pressure to offer appealing and hyper personalized services to acquire and retain customers. Also, the technology advancements have widened the scope of CSPs to focus on new business avenues of digital services and IoT/Enterprise services to fight the disruptions and to stay relevant in the Retail and Enterprise Segment.

Tecnotree DOCS system is designed to support existing and futuristic monetization requirements of CSPs across the verticals and industries. Based on the latest 3GPP (3rd Generation Partnership Project) recommendations & TM Forum open API standards, Tecnotree’s DOCS platform enables CSPs to build, launch and monetize their own as well as create partner offerings to generate new revenue streams quickly. It supports multiple charging models including monetary, events, subscriptions as well as multiple payment models. In addition, DOCS supports network slice-based Charging, Policy and QoS management, AI/ML capabilities for real-time recommendations, and personalized notifications.

“We strongly believe that telco partners and CSPs should be empowered to deliver new digital offerings and enhanced customer experience to their end customers. Thus, we have not limited our offerings to only telco services but have extended our digital BSS suite portfolio with new Convergent Charging Solutions for new age 5G and IoT based Service Providers,” said Leena Koskelainen, Tecnotree Chief Operating Officer (COO).

She further commented, “DOCS is going to be the cornerstone for CSPs to monetize the 5G investments as it can also be implemented to cater to specific 5G services with co-existing deployment models along with your current Online Charging Systems.”

Tecnotree state-of-the-art DOCS solution allows CSPs to innovate, build, deliver and monetize new experiences with advanced pricing and real-time exposure to partners and marketplaces. The DOCS is also empowered with Digital Wallet capabilities allowing customers to do various monetary actions including recharge and auto-top-ups, bill payments, management of loyalty points, as well as buying new telco and non-telco services.

ABOUT TECNOTREE

Tecnotree is the only full-stack digital business management solution provider for digital service providers, with over 40 years of deep domain knowledge, proven delivery, and transformation capability across the globe. Our open-source technology-based agile products and solutions comprise the full range (order-to-cash) of business process and subscription management for telecom and other digital service providers. Tecnotree products and platforms service over 800 million subscribers worldwide. Tecnotree is listed on Nasdaq Helsinki (TEM1V). For more information, please visit our website www.tecnotree.com or social media channels – LinkedIn I Facebook I Twitter

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Padma Ravichander, CEO Tecnotree OYJ
Email: marketing@tecnotree.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 12:11:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 10:00:00 EEST | Press release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 09:00:00 EEST | Press release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 07:30:00 EEST | Press release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 04:00:00 EEST | Press release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye